-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Jr4qB/yTJS/Ju+v8DsD9iEfUEcQO8YG/+KNQoScRMgJSihX49671HZKF6WvJDtdO udZ1lzeX1l8DrM3B/jjkhQ== 0001209191-05-006286.txt : 20050202 0001209191-05-006286.hdr.sgml : 20050202 20050202164155 ACCESSION NUMBER: 0001209191-05-006286 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050131 FILED AS OF DATE: 20050202 DATE AS OF CHANGE: 20050202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KELLY MICHAEL /NMN/ CENTRAL INDEX KEY: 0001236486 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23736 FILM NUMBER: 05569872 MAIL ADDRESS: STREET 1: C/O GUILFORD PHARMACEUTICALS INC STREET 2: 661 TIBUTARY STREET CITY: BALTIMORE STATE: MD ZIP: 21224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GUILFORD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000918066 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521841960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY ST CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2005-01-31 0 0000918066 GUILFORD PHARMACEUTICALS INC GLFD 0001236486 KELLY MICHAEL /NMN/ C/O GUILFORD PHARMACEUTICALS 6611 TRIBUTARY ST. BALTIMORE MD 21224 0 1 0 0 VP, Commercial Operations Restricted Stock Units 2005-01-31 4 A 0 3300 4.66 A 3300 D Common Stock 3540 I 401(K) Stock Options (Right to buy) 4.66 2005-01-31 4 A 0 20000 4.66 A 2006-01-31 2015-01-31 Common Stock 20000 20000 D Stock Options (Right to buy) 4.97 2003-12-01 2012-12-01 Common Stock 50000 50000 D Stock Options (Right to buy) 7.94 2005-02-18 2014-02-18 Common Stock 30000 30000 D The restricted stock units to which this note relates vest as to 25% of such stock units on the first anniversary of the date of grant, and every six months thereafter as to 12.5% of such stock units. Consists of options granted under the Company's 2002 Stock Award and Incentive Plan which shall become exercisable to the extent of 25% of the shares underlying such option on the above date and shall become cumulatively exercisable to the extent of 1/36 of the remaining shares underlying such option each month thereafter. Asher M. Rubin, Attorney-in-fact 2005-02-02 -----END PRIVACY-ENHANCED MESSAGE-----